Residential College | true |
Status | 已發表Published |
Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin | |
Ruting ZHONG1; Mohamed A. Farag2; Meiwan Che1; Chengwei He1; Jianbo Xiao3 | |
2022-06 | |
Source Publication | eFood |
ISSN | 2666-3066 |
Volume | 3Issue:e3 |
Abstract | Fisetin is one of the most popular flavonoids found in vegetables and fruits with several health benefits such as antidiabetic, anticancer, and anti-inflammatory activities. Biotechnology or chemosynthesis tools were used for the synthesis of fisetin and its analogs to improve their yield and efficacy. Structure activity relationships (SARs) revealed that the aromatic hydroxyl groups especially the 3,4-dihydroxylation at ring B were crucial for fisetin biological activities, whereas substitution of several hydroxyl groups in fisetin appeared to impact its original effects. The ongoing or upcoming clinical trials containing fisetin are applied in drugs and dietary supplements. Noteworthily, fisetin has been successfully incorporated into nutraceuticals in the market. Furthermore, the delivery system of fisetin-loaded nanocochleates showed the best bioavailability compared to other formulations. This review presents the latest research progress of fisetin on its synthesis, structure–activity relationships, pharmacokinetics, biological activities, and underlying mechanisms, bioavailability, delivery systems, and clinical trials to provide a comprehensive insight into the research and application of this valuable natural compound. |
Keyword | Bioactivities Fisetin Molecular Mechanism Pharmacokinetics Structure–activity Relationship |
DOI | 10.1002/efd2.3 |
URL | View the original |
Language | 英語English |
Funding Project | Studies on the chemical components and mechanisms for the anti-rheumatoid arthritic activity of Glycine tabacina extract |
Publisher | Wiley Online Library |
Scopus ID | 2-s2.0-85131635796 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | Institute of Chinese Medical Sciences |
Corresponding Author | Ruting ZHONG; Mohamed A. Farag; Meiwan Che; Jianbo Xiao |
Affiliation | 1.University of Macau 2.Cairo University 3.Universidade de Vigo |
First Author Affilication | University of Macau |
Corresponding Author Affilication | University of Macau |
Recommended Citation GB/T 7714 | Ruting ZHONG,Mohamed A. Farag,Meiwan Che,et al. Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin[J]. eFood, 2022, 3(e3). |
APA | Ruting ZHONG., Mohamed A. Farag., Meiwan Che., Chengwei He., & Jianbo Xiao (2022). Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin. eFood, 3(e3). |
MLA | Ruting ZHONG,et al."Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin".eFood 3.e3(2022). |
Files in This Item: | Download All | |||||
File Name/Size | Publications | Version | Access | License | ||
eFood - 2022 - Zhong(8684KB) | 期刊论文 | 作者接受稿 | 开放获取 | ODC ODbL | View Download |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment